127
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Continuing decline in hormone therapy use: population trends over 17 years

, , &
Pages 122-130 | Received 16 Nov 2008, Accepted 04 Dec 2008, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

David F. Archer, Brian A. Bernick & Sebastian Mirkin. (2019) A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause. Expert Review of Clinical Pharmacology 12:8, pages 729-739.
Read now
James H Pickar, David F Archer, Risa Kagan, JoAnn V Pinkerton & Hugh S Taylor. (2017) Safety and benefit considerations for menopausal hormone therapy. Expert Opinion on Drug Safety 16:8, pages 941-954.
Read now
W. Peng, D. W. Sibbritt, L. Hickman, X. Kong, L. Yang & J. Adams. (2014) A critical review of traditional Chinese medicine use amongst women with menopausal symptoms. Climacteric 17:6, pages 635-644.
Read now
H. G. Burger, A. H. MacLennan, K-E. Huang & C. Castelo-Branco. (2012) Evidence-based assessment of the impact of the WHI on women's health. Climacteric 15:3, pages 281-287.
Read now
M. Andrikoula, D. Baker, J. Nesic, L. M. Liao, T. Duka & G. M. Prelevic. (2011) The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women. Climacteric 14:5, pages 544-550.
Read now
LynnA. Morrison, LynnetteL. Sievert, DanielE. Brown, Nichole Rahberg & Angela Reza. (2010) Relationships Between Menstrual and Menopausal Attitudes and Associated Demographic and Health Characteristics: The Hilo Women's Health Study. Women & Health 50:5, pages 397-413.
Read now

Articles from other publishers (26)

G. M. Hamed, N. A. Nassef, R. S. A. E. Mansour, M. K. E. Shawky, A. A. Abo Zeid & A. A. Hassan. (2021) The Effect of Early Application of a Combined Therapy of Bone Marrow Mesenchymal Stem Cells and Platelet-Rich Plasma on Blood and Bone Parameters in Ovariectomized Rats. Journal of Evolutionary Biochemistry and Physiology 57:4, pages 972-990.
Crossref
Usha SalagameErich V. KliewerAlain DemersEmily BanksLouiza S. VelentzisDavid GoldsburySam EggerWilliam D. LeslieKaren Canfell. (2020) Trends in Prescribing Menopausal Hormone Therapy and Bisphosphonates in Australia and Manitoba, Canada and Adherence to Recommendations. Journal of Women's Health 29:2, pages 177-186.
Crossref
James K. Pru. (2019) Persistent concerns over the use of compounded hormone therapies. Menopause 26:9, pages 945-946.
Crossref
Usha Salagame, Emily Banks, Dianne L. O’Connell, Sam Egger & Karen Canfell. (2018) Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study. PLOS ONE 13:11, pages e0205034.
Crossref
Thibaut Benoit, Marie-Cecile Valera, Coralie Fontaine, Melissa Buscato, Francoise Lenfant, Isabelle Raymond-Letron, Florence Tremollieres, Michel Soulie, Jean-Michel Foidart, Xavier Game & Jean-Francois Arnal. (2017) Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation. The American Journal of Pathology 187:11, pages 2499-2507.
Crossref
Ginger D Constantine, Shelli Graham, Cathy Clerinx, Brian A Bernick, Mitchell Krassan, Sebastian Mirkin & Heather Currie. (2016) Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries. Post Reproductive Health 22:3, pages 112-122.
Crossref
Ginger D. Constantine, Risa Kagan & Paul D. Miller. (2016) Effects of ospemifene on bone parameters including clinical biomarkers in postmenopausal women. Menopause 23:6, pages 638-644.
Crossref
Usha Salagame, Emily Banks, Freddy Sitas & Karen Canfell. (2016) Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study. International Journal of Cancer 138:8, pages 1905-1914.
Crossref
JoAnn V. Pinkerton & Ginger D. Constantine. (2016) Compounded non-FDA–approved menopausal hormone therapy prescriptions have increased. Menopause 23:4, pages 359-367.
Crossref
Louiza S. Velentzis, Emily Banks, Freddy Sitas, Usha Salagame, Eng Hooi Tan & Karen Canfell. (2016) Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study. PLOS ONE 11:3, pages e0146494.
Crossref
Zeynep Madak-Erdogan, Ping Gong, Yiru Chen Zhao, Liwen Xu, Kinga U. Wrobel, James A. Hartman, Michelle Wang, Anthony Cam, Urszula T. Iwaniec, Russell T. Turner, Nathan C. Twaddle, Daniel R. Doerge, Ikhlas A. Khan, John A. Katzenellenbogen, Benita S. Katzenellenbogen & William G. Helferich. (2016) Dietary licorice root supplementation reduces diet-induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary gland. Molecular Nutrition & Food Research 60:2, pages 369-380.
Crossref
Margery L.S. Gass, Cynthia A. Stuenkel, Wulf H. Utian, Andrea LaCroix, James H. Liu & Jan L. Shifren. (2015) Use of compounded hormone therapy in the United States. Menopause 22:12, pages 1276-1285.
Crossref
James H. Pickar, Charles Bon, Julia M. Amadio, Sebastian Mirkin & Brian Bernick. (2015) Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. Menopause 22:12, pages 1308-1316.
Crossref
JoAnn V. Pinkerton & Nanette Santoro. (2015) Compounded bioidentical hormone therapy. Menopause 22:9, pages 926-936.
Crossref
Sebastian Mirkin, Julia M. Amadio, Brian A. Bernick, James H. Pickar & David F. Archer. (2015) 17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review. Maturitas 81:1, pages 28-35.
Crossref
Wenbo Peng, Jon Adams, David W. Sibbritt & Jane E. Frawley. (2014) Critical review of complementary and alternative medicine use in menopause. Menopause 21:5, pages 536-548.
Crossref
Katherine M. NewtonSusan D. ReedLarissa NekhyludovLouis C. GrothausEvette J. LudmanKelly EhrlichAndrea Z. LaCroix. (2014) Factors Associated with Successful Discontinuation of Hormone Therapy. Journal of Women's Health 23:5, pages 382-388.
Crossref
Christopher GreenRichard WilliamsRakesh KandaJohn ChurchleyYing He, Shaun Thomas, Peter Goonan, Anu Kumar & Susan Jobling. (2013) Modeling of Steroid Estrogen Contamination in UK and South Australian Rivers Predicts Modest Increases in Concentrations in the Future. Environmental Science & Technology 47:13, pages 7224-7232.
Crossref
Kerri R. Beckmann, Gelareh Farshid, David M. Roder, Janet E. Hiller & John W. Lynch. (2013) Impact of hormone replacement therapy use on mammographic screening outcomes. Cancer Causes & Control 24:7, pages 1417-1426.
Crossref
Anne Marie Whelan, Tannis M Jurgens & Melanie Trinacty. (2012) Bioidentical Progesterone Cream for Menopause-Related Vasomotor Symptoms: Is it Effective?. Annals of Pharmacotherapy 47:1, pages 112-116.
Crossref
Mickaël Hiligsmann, Olivier Bruyère, Dominique Roberfroid, Cécile Dubois, Yves Parmentier, Joëlle Carton, Johann Detilleux, Pierre Gillet & Jean-Yves Reginster. (2012) Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007). Arthritis Care & Research 64:5, pages 744-750.
Crossref
Tanmai Saxena, Eunjung Lee, Katherine D. Henderson, Christina A. Clarke, Dee West, Sarah F. Marshall, Dennis Deapen, Leslie Bernstein & Giske Ursin. (2010) Menopausal Hormone Therapy and Subsequent Risk of Specific Invasive Breast Cancer Subtypes in the California Teachers Study. Cancer Epidemiology, Biomarkers & Prevention 19:9, pages 2366-2378.
Crossref
Kylie A. O'Brien, Euhna Varigos, Catherine Black & Paul A. Komesaroff. (2010) Laser acupuncture does not improve menopausal symptoms. Menopause 17:3, pages 636-641.
Crossref
Joan Tan Garcia, Florante Gonzaga, Delfin Tan, Toon Yaa Ng, Pau Ling Oei & Cathryn W.B. Chan. (2010) Use of a multibotanical (Nutrafem) for the relief of menopausal vasomotor symptoms. Menopause 17:2, pages 303-308.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:9.
Crossref
Alastair H MacLennan. (2009) Evidence-based review of therapies at the menopause. International Journal of Evidence-Based Healthcare 7:2, pages 112-123.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.